Your browser doesn't support javascript.
loading
Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel.
Capodanno, Davide; Morice, Marie-Claude; Angiolillo, Dominick J; Bhatt, Deepak L; Byrne, Robert A; Colleran, Roisin; Cuisset, Thomas; Cutlip, Donald; Eerdmans, Pedro; Eikelboom, John; Farb, Andrew; Gibson, C Michael; Gregson, John; Haude, Michael; James, Stefan K; Kim, Hyo-Soo; Kimura, Takeshi; Konishi, Akihide; Leon, Martin B; Magee, P F Adrian; Mitsutake, Yoshiaki; Mylotte, Darren; Pocock, Stuart J; Rao, Sunil V; Spitzer, Ernest; Stockbridge, Norman; Valgimigli, Marco; Varenne, Olivier; Windhovel, Ute; Krucoff, Mitchel W; Urban, Philip; Mehran, Roxana.
Affiliation
  • Capodanno D; Division of Cardiology, Azienda Ospedaliero Universitario "Policlinico G. Rodolico-San Marco", University of Catania, Catania, Italy. Electronic address: dcapodanno@unict.it.
  • Morice MC; Cardiovascular European Research Center, Massy, France. Electronic address: https://twitter.com/mc_morice.
  • Angiolillo DJ; Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida.
  • Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center, Harvard Medical School, Boston, Massachusetts. Electronic address: https://twitter.com/DLBhattMD.
  • Byrne RA; Cardiovascular Research Institute Dublin, Mater Private Hospital, Dublin, Ireland; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, Ireland. Electronic address: https://twitter.com/robebyrne.
  • Colleran R; Cardiovascular Research Institute Dublin, Mater Private Hospital, Dublin, Ireland; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany.
  • Cuisset T; Département de Cardiologie, Centre Hospitalier Universitaire Timone and Inserm, Inra, Centre de Recherche en Cardiovasculaire et Nutrition, Faculté de Médecine, Aix-Marseille Université, Marseille, France. Electronic address: https://twitter.com/CuissetDr.
  • Cutlip D; Cardiology Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address: https://twitter.com/DonaldCutlip.
  • Eerdmans P; DEKRA Certification, Arnhem, the Netherlands.
  • Eikelboom J; Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Farb A; U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Gibson CM; Harvard Medical School, Boston, Massachusetts; Baim Institute for Clinical Research, Brookline, Massachusetts. Electronic address: https://twitter.com/CMichaelGibson.
  • Gregson J; London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Haude M; Städtische Kliniken Neuss, Lukaskrankenhaus, Neuss, Germany.
  • James SK; Department of Medical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  • Kim HS; Cardiovascular Center, Seoul National University Hospital, Seoul, Korea.
  • Kimura T; Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Konishi A; Office of Medical Devices 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Leon MB; Columbia University Medical Center, New York, New York; Cardiovascular Research Foundation, New York, New York. Electronic address: https://twitter.com/MartyMleon.
  • Magee PFA; U.S. Food and Drug Administration, Silver Spring, Maryland. Electronic address: https://twitter.com/dmylotte.
  • Mitsutake Y; Office of Medical Devices 1, Pharmaceuticals and Medical Devices Agency, Tokyo, Japan.
  • Mylotte D; University Hospital and National University of Ireland, Galway, Ireland.
  • Pocock SJ; London School of Hygiene and Tropical Medicine, London, United Kingdom.
  • Rao SV; Duke Clinical Research Institute, Durham, North Carolina. Electronic address: https://twitter.com/SVRaoMD.
  • Spitzer E; Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands; Cardialysis, Clinical Trial Management and Core Laboratories, Rotterdam, the Netherlands. Electronic address: https://twitter.com/ernest_spitzer.
  • Stockbridge N; U.S. Food and Drug Administration, Silver Spring, Maryland.
  • Valgimigli M; Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland. Electronic address: https://twitter.com/vlgmrc.
  • Varenne O; Service de Cardiologie, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris, Paris, France; Université Paris Descartes, Sorbonne Paris-Cité, Paris, France.
  • Windhovel U; Cardiovascular European Research Center, Massy, France. Electronic address: https://twitter.com/Urphi.
  • Krucoff MW; Duke Clinical Research Institute, Durham, North Carolina; Duke University Medical Center, Durham, North Carolina. Electronic address: https://twitter.com/mwkrucoff.
  • Urban P; La Tour Hospital, Geneva, Switzerland.
  • Mehran R; Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: https://twitter.com/Drroxmehran.
J Am Coll Cardiol ; 76(12): 1468-1483, 2020 09 22.
Article in En | MEDLINE | ID: mdl-32943165
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Percutaneous Coronary Intervention / Hemorrhage Type of study: Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: En Journal: J Am Coll Cardiol Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Clinical Trials as Topic / Percutaneous Coronary Intervention / Hemorrhage Type of study: Etiology_studies / Guideline / Risk_factors_studies Limits: Humans Language: En Journal: J Am Coll Cardiol Year: 2020 Document type: Article Country of publication: